In Brief OmniaBio opens commercial manufacturing facility in Canada, bringing cell and gene therapies to patients October 25, 2024Vol.50 No.40
Clinical Roundup Medicaid expansion may improve cancer care and survival for people with HR-negative, HER2-positive breast cancer October 25, 2024Vol.50 No.40
Clinical Roundup Starving cancer cells of fat may improve cancer treatment October 25, 2024Vol.50 No.40
Clinical Roundup Tracing cancer back to birth uncovers promising biomarkers for prevention, early detection, targeted treatment of childhood leukemia October 25, 2024Vol.50 No.40
Clinical Roundup Preclinical data suggest WRN inhibitor may be viable treatment for MSI-H tumors October 25, 2024Vol.50 No.40
Clinical Roundup East Alabama Medical Center, Inflo Health, ACR ImPower program collaboration boosts recommendations follow-up by 74% October 25, 2024Vol.50 No.40
Drugs & Targets FDA approves Vyloy+chemo for gastric or GEJ junction adenocarcinoma with CLDN18.2-positive tumors October 25, 2024Vol.50 No.40
Drugs & Targets FDA accepts NDA, grants priority review for Pixclara glioma imaging agent October 25, 2024Vol.50 No.40
